• SENSEX 76,024.51
    -1,390.41 (--1.80%)
  • BANKNIFTY 50,827.50
    -737.35 (--1.43%)
  • Vodafone Idea
    8.57 19.15(%)
  • Hind.Aeronautics
    4,492.80 5,675.00(%)
  • HBL Engineering
    532.15 738.65(%)
  • Reliance Industr
    1,250.00 1,156.00(%)
  • HDFC Bank
    1,765.00 1,430.15(%)
  • Galaxy Surfact.
    2,096.20 3,366.30(%)
  • Adani Green
    916.95 758.00(%)
  • ICICI Bank
    1,315.00 1,048.35(%)
  • Zomato Ltd
    205.00 304.50(%)
  • Larsen & Toubro
    3,430.60 3,141.30(%)
  • Infosys
    1,518.00 1,359.10(%)
  • Bajaj Finance
    8,672.00 6,376.55(%)
  • Dixon Technolog.
    12,880.05 7,100.05(%)
  • IndusInd Bank
    689.85 1,576.00(%)
  • ITC
    405.50 381.24(%)
  • Nip. India Gold
    77.05 77.05(%)
  • St Bk of India
    763.05 679.65(%)
  • M & M
    2,625.00 1,891.30(%)
  • Trent
    5,619.85 8,345.85(%)
  • PB Fintech.
    1,505.90 1,110.25(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Coral Laboratories Ltd Pharmaceuticals - Indian - Formulations

  • Coral
  • BSE Code : 3676.0
  • ISIN : INE683E01017
703.80 2 (0.34%)
  • As on 02 Apr 2025 (EOD)

  • Today’s Low

    695.00

  • Today’s High

    712.90

  • Open

    701.40

  • Perv Close

    701.40

  • 52W Low

    355.00

  • 52W High

    999.00

Key Indicators

  • P/E(TTM)

    9.24

  • Mar.Cap (₹Cr.)

    251.26

  • Div & Yield %

    0.00

  • Book Value(₹)

    570.15

  • Debt-Equity Ratio

    0.34

  • AGM Date

    01-Apr-2025

  • EPS

    76.14

  • P/E Ratio

    9.24

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    251.26

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.57

  • BV (₹)

    570.20

  • Sales( ₹ in Cr.)

    83.66

  • NP (in Cr.)

    15.91

  • NP Var(%)

    148.0

  • Div%

    0.0

  • CPS (₹)

    50.10

  • EPS (₹)

    44.60

  • Traded Value (₹ in Lakhs)

    251.26

  • 52 Week High

    999.00

  • 52 Week Low

    355.00

  • Price BSE

    704.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    251.26

  • P/C Ratio

    14.00

  • P/E Ratio

    15.80

  • Price Vs.BV

    44.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 83.66 78.12 75.61 96.57 70.58 91.08
Excise Duty 82.10 77.89 73.22 95.21 68.25 88.30
Net Sales 83.66 78.12 75.61 96.57 70.58 91.08
Other Income 6.63 6.90 4.81 3.77 5.89 5.16
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 90.29 85.01 80.42 100.34 76.47 96.24
EXPENDITURE :
Raw Materials 82.10 77.89 73.22 95.21 68.25 88.30
Power & Fuel Cost 82.10 77.89 73.22 95.21 68.25 88.30
Employee Cost 11.20 11.13 11.23 10.18 9.70 9.84
Other Manufacturing Expenses 3.57 0.23 0.28 3.29 2.66 2.55
Selling & Administrative Expenses 8.39 9.55 9.61 9.32 6.45 6.53
Miscellaneous Expenses 3.57 0.23 0.28 3.29 2.66 2.55
Less : Pre-operative Expenses Capitalised :
Total Expenditure 69.40 76.83 69.53 82.74 67.35 80.73
Operating Profit 7.01 7.65 6.56 7.86 6.45 9.12
Interest 0.00 0.34 0.14 0.04 0.06 0.02
Gross Profit 20.73 8.23 11.86 17.61 9.12 15.51
Depreciation 1.98 2.18 1.99 1.98 2.01 1.90
Profit Before Tax 20.73 8.23 11.86 17.61 9.12 15.51
Tax 4.91 1.82 2.75 4.50 2.50 5.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.03 -0.04 0.06 -0.44 -0.51 0.29
Reported Net Profit 15.79 6.45 9.05 13.55 7.13 10.22
Extraordinary Items 20.73 8.23 11.86 17.61 9.12 15.51
Adjusted Net Profit 15.79 6.45 9.05 13.55 7.13 10.22
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.71
P & L Balance carried down 15.79 6.45 9.05 13.55 7.13 10.22
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 20.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 2.00
Earnings Per Share-Unit Curr 44.19 18.04 25.32 37.94 19.96 28.60
Book Value 0.00 0.00 0.00 0.00 0.00 0.71
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.71

Shareholding Pattern

  • Promoter Group

    71.51%

  • Public Share Holding

    28.49%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,841,453 1,841,453.00 1,841,453 1,841,453
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,841,453 51.54 1,841,453 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 713,351 19.97 713,351 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 713,351 19.97 713,351 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 42,382 1.19 42,082 28
Clearing Members 100 0.00 100 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 96,896 2.71 92,896 112
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 39,337 1.10 39,337 133
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 120,268 3.37 120,268 3
Individuals holding nominal share capital up to Rs. 1 lakh 629,595 17.62 577,054 3,771
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 88,917 2.49 88,917 1
Sub Total 1,017,796 28.49 960,955 4,052
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,572,600 100.00 3,515,759 4,054

Company Background

Coral Laboratories LtdPharmaceuticals - Indian - Formulations

  • Coral Laboratories Ltd
  • BSE Code : 3676.0
  • ISIN : INE683E01017

  • Incorporation Year

    1981

  • Registered Office

    SF-206 Silver Oak Complex
    BPC Road, Vadodara,
    Gujarat-390020

  • Telephone

    91-022-2500 5245/46

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Dhwani Desai

  • Auditor

    M A Parekh & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Coral Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Coral Labs. 703.80 90.29 83.66 9.27 12.26
Abbott India 30,305.85 6,097.18 5,848.91 48.26 44.71
Astrazeneca Phar 8,518.55 1,330.33 1,295.53 219.61 33.26
P & G Health Ltd 5,152.30 1,166.89 1,151.26 36.15 39.76
Glaxosmi. Pharma 2,793.40 3,530.73 3,407.25 55.55 44.44
Cipla 1,444.55 17,645.00 16,574.34 24.77 20.10
Amrutanjan Healt 642.85 437.58 421.23 37.68 20.84
Fermenta Biotec. 285.30 315.24 307.09 27.04 4.10
Guj. Themis Bio. 271.85 174.19 169.82 56.28 44.82
Bliss GVS Pharma 119.25 638.96 605.46 27.29 11.19
Ambalal Sarabhai 36.15 11.70 3.81 15.45 1.92